ROSEMARIE MURPHY: Open Payments
NPI 1386411478 · ROCKINGHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,809 in 100 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $827 · 2025 $1,809
Food & beverage: $1,809
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $601 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $319 |
| Vanda Pharmaceuticals Inc. | 15 | $251 |
| Supernus Pharmaceuticals, Inc. | 14 | $151 |
| Indivior Inc. | 6 | $141 |
| Janssen Pharmaceuticals, Inc | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Lundbeck LLC | 2 | $46 |
| Alkermes, Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
Products named: VRAYLAR, CAPLYTA, FANAPT, Qelbree, SUBLOCADE, REXULTI, SPRAVATO, VIVITROL.
Industry payments across NC — which companies pay providers there.
